Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development
Saved in:
Main Authors: | Rui Li (Author), Morgan Craig (Author), David Z. D'Argenio (Author), Alison Betts (Author), Donald E. Mager (Author), Tristan S. Maurer (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple Myeloma
by: Vidya Ramakrishnan, et al.
Published: (2019) -
Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3‐mimetics using virtual tumors calibrated with cell viability assays
by: Thibaud Derippe, et al.
Published: (2024) -
Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
by: Sihem Ait-Oudhia, et al.
Published: (2014) -
Editorial: Shaping with data: Using pharmacoepidemiology to shape pharmaceutical policy and clinical decision-making
by: Mina Tadrous, et al.
Published: (2022) -
Pharmacy Interns' Perception of Climate Change and Its Impact on Health
by: Cecilia Speck, et al.
Published: (2024)